Home » Topics » Regulatory

Regulatory
RSS

Korean approval for Quinvaxem pentavalent vaccine

March 29, 2006

Aranesp approved for every-three-week dosing

March 28, 2006

Lyrica receives European approval for GAD

March 28, 2006

Swedish approval for Grazax for grass pollen allergy

March 16, 2006

Emsam approved for major depressive disorder

March 1, 2006

Eraxis approved to treat candidemia

Feb. 22, 2006

RotaTeq receives FDA approval

Feb. 7, 2006

Clarinex-D 12 Hour approved for seasonal allergic rhinitis

Feb. 3, 2006

Amitiza approved for chronic idiopathic constipation

Feb. 2, 2006

European approval for Ionsys in postoperative pain

Jan. 31, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...